Anti-cancer Effects of a Chemically Modified miR-143 on Bladder Cancer by Either Systemic or Intravesical Treatment-Reference-Cited by-同舟云学术

Anti-cancer Effects of a Chemically Modified miR-143 on Bladder Cancer by Either Systemic or Intravesical Treatment

Published:2019-06 Issue: Volume:13 Page:290-302
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Yoshikawa Yuki,Taniguchi Kohei,Tsujino Takuya,Heishima Kazuki,Inamoto Teruo,Takai Tomoaki,Minami Koichiro,Azuma Haruhito,Miyata Kanjiro,Hayashi Kotaro,Kataoka Kazunori,Akao Yukihiro

Funder

Japan Agency for Medical Research and Development

SHIONOGI

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference40 articles.

1. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update;Hall;J. Urol.,2007

2. Natural history and treatment of low and high risk superficial bladder tumors;Rübben;J. Urol.,1988

3. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder;Gakis;Eur. Urol.,2013

4. Population-based trends in urinary diversion among patients undergoing radical cystectomy for bladder cancer;Kim;BJU Int.,2013

5. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44;Yu;J. Exp. Clin. Cancer Res.,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor effects of chemically modified miR-143 lipoplexes in a mouse model of pelvic colorectal cancer via myristoylated alanine-rich C kinase substrate downregulation;Molecular Therapy - Nucleic Acids;2023-12

2. The Nanotechnology-Based Approaches against Kirsten Rat Sarcoma-Mutated Cancers;Pharmaceutics;2023-06-08

3. Clinical Value Analysis of Xiaozheng Decoction Combined with Bladder Perfusion for Postoperative Treatment of Bladder Cancer and Its Effect on Serum miR-143 and miR-92a;Journal of Healthcare Engineering;2022-03-24

4. Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer;Frontiers in Oncology;2022-02-11

5. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling;Technology in Cancer Research & Treatment;2022-01